The back-lash of the 2007/2008 global financial crisis led to pressure from governments reducing healthcare budgets. This, in turn, left the global prescription market feeling the pinch. But with the global population ageing, the rise of chronic illnesses and universal healthcare schemes being unveiled worldwide, the prescription drug market has the opportunity for growth – but in what countries?

Key Market Questions Answered by The World Prescription Drug Market Report:

• Which country has the highest prescription drug expenditure?
• Which Middle East country is forecast to have the strongest growth?
• What is the number of dispensed prescriptions in the US, by therapy area?
• How does the Brazilian market compare with China, Russia and India, historically?
• What are the key trends affecting the Latin American countries?

The World Prescription Drugs Market Report 2013 is the perfect accomplice for any industry executive in today’s challenging global market environment. The need for hard facts and statistics to back up everyday business decisions is essential and it is this report that can provide you with that key information.

With hundreds of comparable data points available, who else will provide you with:

• Our exclusive analysts industry opinion – not found anywhere else!
• Key historical data and industry forecasts for 72 countries worldwide
• In-depth prescription drug sale indicators for 2009 – 2017
• Detailed tables and representative graphs with key comparisons such as the top 30 markets by value and by per-capita spending

Table Of Contents

BMI Industry View 9

Industry Forecast 15

Africa 15

Algeria 16

Table: Algeria Prescription Drug Market Indicator. Historical Data and Forecasts 17

Egypt18

Table: Egypt Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 19

Ghana 20

Table: Prescription Drug Sales. 2009-2017 21

Kenya 22

Table: Kenya Prescription Drug Market Indicators, Historical Data and Forecasts 23

Morocco 24

Table: Leading Therapeutic Classes. 2010 25

Table: Private Pharmacy Sales Value and Volume Bi Principal Therapeutic Categories. 2010 26

Table: Morocco Prescription Drug Market Indicators, Historical Data and Forecasts 26

Nigeria 27

Table: Nigeria Prescription Drug Market Indicators, Historical Data and Forecasts 29

South Africa

Table: South Africa Prescription Drug Market Indicators, Historical Data, and Forecasts 31

Industry Forecast 32

Asia Pacific 32

Australia 33

Table: Pharmaceutical Sales. 2009-2017 34

Bangladesh 35

Table: Bangladesh Prescription Drug Market Indicators, Historical Data And Forecasts 36

China 37

Table: Prescription Drug Sales Indicators. 2009-2017 38

Hong Kong 39

Table: Prescription Drug Sales Indicators. 2009-20! 7 40

India 41

Table: Prescription Drug Sales. 2009-2017 42

Indonesia 43

Table: Indonesia Prescription Drug Market Indicators, Historical Data and Forecasts 44

Japan 45

Table: Prescription Drug Market Indicators, Historical Data And Forecasts 46

Malaysia 47

Table: Prescription Drug Sales Indicators 2009-2017 48

New Zealand 49

Table: New Zealand Prescription Drug Market Indicators, Historical Data and Forecasts 50

Pakistan 51

Table: Pakistan Prescription Drug Market Indicators, Historical Data and Forecasts 53

Philippines 54

Table: Philippines Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017

Singapore 56

Table: Pharmaceutical Sales Indicators 2009-2017 57

South Korea 58

Table: South Korea Prescription Drug Market Indicators, Historical Data and Forecasts 59

Taiwan 60

Table: Taiwan Prescription Drug Market Indicators, Historical Data and Forecasts 61

Thailand 62

Table: Thailand Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 63

Vietnam 64

Table: Prescription Drug Sales Indicators. 2009-2017 66

Industry Forecast 67

Europe 67

Belarus 68

Table: Belarus Prescription Drug Market Indicators, Historical Data and Forecasts 69

Belgium 70

Table: Belgium Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 71

Bulgaria 72

Table: Bulgaria Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 74

Table: Leading ATC Groups by Volume, 2009 74

Table: Leading ATC Groups by Value, 2009 75

Croatia 76

Table: Croatia Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2018 78

Czech Republic 79

Table: Czech Prescription Drug Market Indicators, Historical Data and Forecast 81

Estonia 82

Table: Leading ATC Groups by Pharmaceutical Sales, 2004-2010 (%) 84

Table: Estonia Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 86

France 87

Table: France Prescription Drug Market Indicators, Historical Data and Forecasts 88

Germany 89

Table: Retail Pharmaceutical Expenditure. 2003-10 (EURbn) 90

Table: Retail Pharmaceutical Expenditure. 2003-10 (Packages, ms) 90

Table: Retail Pharmaceutical Expenditure. 2003-10 (Average Price per Pack, EUR) 91

Table: Germany Prescription Drug Market Indicators, Historical Data and Forecasts 92

Greece 93

Table: Prescription Drug Sales Indicators. 2009-2017 94

Hungary 95

Table: Hungary Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 96

Italy 97

Table: Prescription Drug Market Indicators, Historical Data and Forecasts 99

Kazakhstan 100

Table: Kazakhstan Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 101

Latvia 102

Table: Latvia Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017 103

Lithuania 104

Table: Lithuania Prescription Drug Market Indicators, Historical Data and Forecasts, 2019-2017 106

Moldova 107

Table: Moldova Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 108

Netherlands 109

Poland 111

Table: Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 112

Portugal 113

Table: Prescription Drug Market Indicators, Historical Data and Forecasts 115

Romania 116

Table: Romania Prescription Drug Market Indicators, Historical Data And Forecasts. 2009-201 7 117

Russia 118

Table: Russia Prescription Drug Marker Indicators, Historical Data and Forecasts 119

Serbia 120

Table: Serbia Prescription Drug Market Indicators, Historical Data and Forecasts 121

Slovakia 122

Table: Prescription Drug Market Indicators, Historical Data and Forecasts 124

Slovenia 125

Table: Slovenia Prescription Drug Market Indicators, Historical Data and Forecasts 126

Spain 127

Table: Spain Prescription Drug Market Indicators, Historical Data and Forecasts 128

Sweden 129

Table: Table: Pharmaceutical Sales By Leading Product At Wholesale Prices. 2007-2010 (SEKmn) 129

Table: Table: Pharmaceutical Sales By Therapeutic Group At Wholesale Prices. 200 7-2010 (SEKmn) 131

Table: Table: Inpatient Hospital Sales By Leading Pharmaceutical Group At Retail Prices. 2007-2010 (SEKmn) 132

Table: Table: Swede,, Prescription Drug Market Indicators, Historical Data And Forecasts 133

Switzerland 134

Table: Switzerland Patented Drug Market Indicators, Historical Data and Forecasts 135

Turkey 136

Table: Turkey Prescription Drug 1.larket Indicators, Historical Data and Forecasts 137

United Kingdom 138

Table: Prescriptions & Cost hr Therapeutic Area in the UK. 2011 139

Table: UK Prescription Drug Market Indicators, Historical Data and Forecasts 143

Ukraine 144

Table: Ukraine - Prescription Drug Market Indicators, Historical Data and Forecasts 145

Uzbekistan 146

Table: Uzbekistan Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 147

Industry Forecast 148

Latin America 148

Argentina 149

Table: Argentina Prescription Drug Market Indicators, Historical Data arid Forecasts 150

Brazil 151

Table: Brazil Prescription Drug Market Indicators, Historical Data And Forecasts 152

Chile 153

Table: Chile Prescription Drug Market Indicators, Historical Data & Forecasts 154

Colombia 155

Table: Colombia Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 156

Mexico 157

Table: Prescription Drug Saks Indicators. 2009-2017 158

Peru 159

Table: Peru Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-201 7 160

Venezuela 161

Table: Prescription Drug Sales. 2009-2017 162

Industry Forecast 163

Middle East 163

Bahrain 164

Table: Bahrain Prescription Drug Market Indicators, Historical Data and Forecasts 165

Iran 166

Israel 168

Table: Israel Prescription Drug Market Indicators, Historical Data and Forecasts 169

Jordan 170

Table: Jordan Prescription Drug Market Indicators, Historical Data and Forecasts 2009-2017 171

Kuwait 172

Table: Prescription Drug Sales Indicators 2009-2017 173

Lebanon 174

Table: Lebanon Prescription Drug Market Indicators, Historical Data and Forecasts. 2009-2017 175

Oman 176

Table: Oman Prescription Drug Market Indicators, Historical Data and Forecasts 2009-2017 177

Qatar 178

Table: Qatar Prescription Drug Market Indicators, Historical Data, and Forecasts 179

Saudi Arabia 180

Table: Saudi Arabia Prescription Drug Market Indicators, Historical Data and Forecasts 181

UAE 182

Table: UAE Healthcare Demand Split by Therapeutic Area 182

Table: Prescription Drug Sales Indicators 20(19-2017 185

Industry Forecast 186

North America 186

Canada 187

Table: Prescription Drug Market Indicators, Historical Data and Forecasts 188

US 189

Table: US Prescription Drug Market Indicators, Historical Data and Forecasts 191

Table: Number Of Dispensed Prescriptions by Therapy Area in the US (mn) 191

Table: Number Of Dispensed Prescriptions by Active Ingredient in the US (mn) 191

Glossary 193

Methodology 195

Pharmaceutical Expenditure Forecast Model 195

Healthcare Expenditure Forecast Model 195

Notes on Methodology 196